Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: An individual patient's data meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 175, Issue 2, 2014, Pages 352-357

  Giallauria, Francesco ^a,b   Vigorito, Carlo ^a   Piepoli, Massimo F ^c   Stewart Coats, Andrew J ^d,e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NEW ENGLAND   (Australia)

^c GUGLIELMO DA SALICETO HOSPITAL   (Italy)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

6 minute walking test; Cardiac contractility modulation; Individual patient data meta analysis; Minnesota Living With Heart Failure Questionnaire; OPTIMIZER device; Peak oxygen consumption

Indexed keywords

6 MINUTE WALKING TEST; ADULT; ANAEROBIC THRESHOLD; ARTICLE; CARDIAC CONTRACTILITY MODULATION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE THERAPY; ELECTROSTIMULATION; EXERCISE; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART STIMULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MINNESOTA LIVING WITH HEART FAILURE QUESTIONNAIRE; MUSCLE STIMULATOR; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; ELECTROSTIMULATION THERAPY; EXERCISE TEST; HEART CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ELECTRIC STIMULATION THERAPY; EXERCISE TEST; HEART FAILURE; HUMANS; MYOCARDIAL CONTRACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84904261392     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.005     Document Type: Article

References (39)

1. J.G. Cleland, J.C. Daubert, and E. Erdmann et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
2. F. Cabrera-Bueno, J. Alzueta, I. Ruiz-Zamora, M.J. Molina-Mora, A. Barrera, and E. de Teresa-Galvan Normalization of left ventricle systolic function after resynchronization therapy in patients with dilated cardiomyopathy Int J Cardiol 158 2012 177 179
3. C.D. Abreu, R.M. Xavier, J.S. Nascimento, and A.L. Ribeiro Long-term outcome after Cardiac Resynchronization Therapy: a nationwide database Int J Cardiol 155 2012 492 493
4. Q. hang, and C. Yu Could exercise unveil the mystery of non-response to cardiac resynchronization therapy? Europace 13 2011 768 769
5. D. Burkhoff, and S.A. Ben Haim Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure Am J Physiol Heart Circ Physiol 288 2005 H2550 H2556
6. J. Winter, K.E. Brack, and G.A. Ng Cardiac contractility modulation in the treatment of heart failure: initial results and unanswered questions Eur J Heart Fail 13 2011 700 710
7. M. Borggrefe, and D. Burkhoff Clinical effects of cardiac contractility modulation as a treatment of chronic heart failure Eur J Heart Fail 14 2012 703 712
8. J.S.W. Kwong, J.E. Sanderson, and C.-M. Yu Cardiac contractility modulation for heart failure: a meta-analysis of randomized controlled trials Pace 35 2012 1111 1118
9. A. Takeda, S.J. Taylor, R.S. Taylor, F. Khan, H. Krum, and M. Underwood Clinical service organisation for heart failure Cochrane Database Syst Rev 9 2012 CD002752
10. Higgins JPT, Altman DG, Sterne JAC (eds). Assessing risk of bias in included studies. In: Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available at: www.cochrane-handbook.org (accessed Jan 3, 2014).
11. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 2009 e1000097
12. J. Myers, L. Gullestad, and R. Vagelos et al. Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited Am Heart J 139 2000 78 84
13. D.P. Francis, W. Shamim, and L.C. Davies et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2) Eur Heart J 21 2000 154 161
14. D.M. Mancini, H. Eisen, W. Kussmaul, R. Mull, L.H. Edmunds Jr., and J.R. Wilson Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
15. C. Demers, R.S. McKelvie, A. Negassa, S. Yusuf, and RESOLVD Pilot Study Investigators Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure Am Heart J 142 2001 698 703
16. T. Rector, S. Kubo, and J. Cohn Patients self-assessment of their congestive heart failure: content, reliability and validity of a new measure - the Minnesota Living with Heart Failure Questionnaire Heart Fail 3 1987 198 209
17. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
18. S.B. Neelagaru, J.E. Sanchez, and S.K. Lau et al. Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration Heart Rhythm 3 2006 1140 1147
19. M.M. Borggrefe, T. Lawo, and C. Butter et al. Randomized, double blind study of nonexcitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure Eur Heart J 29 2008 1019 1028
20. A. Kadish, K. Nademanee, and K. Volosin et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure Am Heart J 161 2011 329-337 (e1-e2.)
21. S. Cazeau, C. Leclercq, and T. Lavergne et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay N Engl J Med 344 2001 873 880
22. W.T. Abraham, W.G. Fisher, and A.L. Smith et al. Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
23. S.L. Higgins, J.D. Hummel, and I.K. Niazi et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias J Am Coll Cardiol 42 2003 1454 1459
24. J.B. Young, W.T. Abraham, and A.L. Smith et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial JAMA 289 2003 2685 2694
25. M.U. Braun, T. Rauwolf, T. Zerm, M. Schulze, A. Schnabel, and R.H. Strasser Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones Heart 91 5 2005 601 605
26. A. Auricchio, C. Stellbrink, and S. Sack et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay J Am Coll Cardiol 39 12 2002 2026 2033
27. S. Garrigue, P. Bordachar, and S. Reuter et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study Heart 87 2002 529 534
28. C. Leclercq, S. Walker, and C. Linde et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation Eur Heart J 23 2002 1780 1787
29. C.C.S. Leclercq, D. Lellouche, and F. Fossati et al. Upgrading from right-ventricular pacing to biventricular pacing in previously paced patients with advanced heart failure: a randomized controlled study Eur Heart J 24 Suppl. S 2003 364
30. M.R. Bristow, L.A. Saxon, and J. Boehmer et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
31. J. Abdulla, J. Haarbo, L. Køber, and C. Torp-Pedersen Impact of implantable defibrillators and resynchronization therapy on outcome in patients with left ventricular dysfunction - a meta-analysis Cardiology 106 4 2006 249 255
32. C. Butter, J. Meyhöfer, M. Seifert, M. Neuss, and H.H. Minden First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: clinical and technical aspects of combined therapies Eur J Heart Fail 9 2007 955 958
33. H. Nagele, S. Behrens, and C. Eisermann Cardiac contractility modulation in nonresponders to cardiac resynchronization therapy Europace 10 2008 1375 1380
34. M. Borggrefe, and D. Burkhoff Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure Eur J Heart Fail 14 2012 703 712
35. C. Manetos, S. Dimopoulos, and G. Tzanis et al. Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure J Heart Lung Transplant 30 2011 1403 1408
36. W.T. Abraham, K. Nademanee, and K. Volosin et al. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure J Card Fail 17 2011 710 717
37. NCT01381172 Evaluate safety and efficacy of the OPTIMIZER system in subjects with NYHA class III heart failure symptoms: FIX-HF-5B Available at: http://clinicaltrials.gov/ct2/show/NCT01381172 (accessed Jan 3, 2014)
38. NCT01789112 Acute neurotrophic effects of a non-excitatory cardial stimulation by Optimizer III System in patients with heart failure Available at: http://clinicaltrials.gov/ct2/show/NCT01789112 (accessed Jan 3, 2014)
39. C.M. Yu, J.Y. Chan, and Q. Zhang et al. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling JACC Cardiovasc Imaging 2 2009 1341 1349